Posted inNews and Updates
Phanes Therapeutics Expands Spevatamig Combo Trial for BTC
Phanes Therapeutics expands its clinical trial with Merck to test Spevatamig alongside KEYTRUDA and chemotherapy for treating biliary tract cancer.
Posted inNews and Updates
Pharmability Receives Approval for Atopic Dermatitis Phase Ib Trial
Pharmability gains Swedish MPA approval for a Phase Ib trial of TIR-C, a promising new therapeutic candidate for treating chronic atopic dermatitis.
Posted inNews and Updates
Bulumtatug Fuvedotin Shows Promise in Pretreated TNBC
Mabwell’s bulumtatug fuvedotin shows clinical potential for triple-negative breast cancer patients previously treated with topoisomerase I inhibitors.
Posted inNews and Updates
4D-150 Shows Long-Term Efficacy in Treating Wet AMD
New 2-year data confirms 4D-150 gene therapy provides sustained vision improvements for wet AMD patients, potentially reducing the need for recurring injections.
Posted inNews and Updates
OMEICOS Advances OMT-28 to Phase 3 for Mitochondrial Disease
OMEICOS has initiated a Phase 3 trial for OMT-28, a potential breakthrough treatment targeting mitochondrial disease. Learn about this new clinical milestone.
Posted inNews and Updates
CMS Targets RPM Vendors: Impacts for Clinical Trial Sponsors
CMS is tightening oversight on RPM vendors. Learn how these regulatory shifts impact data integrity and compliance for clinical trial sponsors.
Posted inNews and Updates
Glofitamab and Englumafusp Alfa: A New Era for Cancer Care
Explore how the innovative combination of Glofitamab and Englumafusp Alfa is revolutionizing cancer therapy in recent Phase 1 clinical trial findings.
Posted inNews and Updates
FDA Grants Priority Review to Z-rostudirsen for Duchenne MD
The FDA has granted Priority Review to Dyne Therapeutics' z-rostudirsen. Learn how this novel therapy aims to treat Duchenne Muscular Dystrophy.
Posted inNews and Updates
FDA Approves Gene Therapy Trial for Tay-Sachs and Sandhoff
The FDA has authorized a new gene therapy trial for Tay-Sachs and Sandhoff diseases. Discover how this breakthrough could redefine treatment for rare disorders.
Posted inNews and Updates
Avatrombopag Study: New Data on Reducing Chemo Delays
New trial data shows oral avatrombopag effectively reduces chemotherapy delays by managing platelet counts, offering a breakthrough for cancer care.